About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [216 citations: 1–100 of 208 articles]

Articles published in Prostate Cancer have been cited 216 times. The following is a list of the 208 articles that have cited the articles published in Prostate Cancer.

  • Nathan A. Berger, “Obesity and cancer pathogenesis,” Annals of the New York Academy of Sciences, vol. 1311, no. 1, pp. 57–76, 2014. View at Publisher · View at Google Scholar
  • Anna Ida Fiaschi, Roberto Petrioli, Filippo Francini, Vincenzo Bianco, Armando Perrella, Giovanni Paganini, Letizia Laera, and Giandomenico Roviello, “Abiraterone in heavily pretreated patients with metastatic castrate-resista nt prostate cancer,” Anti-Cancer Drugs, vol. 25, no. 4, pp. 472–477, 2014. View at Publisher · View at Google Scholar
  • Katsura Kakoki, Haruka Kamiyama, Mai Izumida, Yuka Yashima, Hideki Hayashi, Naoki Yamamoto, Toshifumi Matsuyama, Tsukasa Igawa, Hideki Sakai, and Yoshinao Kubo, “Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus,” Biochemical and Biophysical Research Communications, 2014. View at Publisher · View at Google Scholar
  • Adam M. Hirst, Fiona M. Frame, Norman J. Maitland, and Deborah O’Connell, “Low Temperature Plasma: A Novel Focal Therapy for Localized Prostate Cancer?,” BioMed Research International, vol. 2014, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Ying Zhang, Thomas Perez, Beth Blondin, Jing Du, Ping Liu, Diana Escarzaga, John S. Coon, and Larry E. Morrison, “Identification of FISH biomarkers to detect chromosome abnormalities associ ated with prostate adenocarcinoma in tumour and field effect environment,” Bmc Cancer, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Lei Chang, Peter H. Graham, Jingli Hao, Joseph Bucci, Paul J. Cozzi, John H. Kearsley, and Yong Li, “Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy,” Cancer and Metastasis Reviews, 2014. View at Publisher · View at Google Scholar
  • Caryn E. Peterson, Garth H. Rauscher, Timothy P. Johnson, Carolyn V. Kirschner, Richard E. Barrett, Seijeoung Kim, Marian L. Fitzgibbon, Charlotte E. Joslin, and Faith G. Davis, “The association between neighborhood socioeconomic status and ovarian cancer tumor characteristics,” Cancer Causes & Control, 2014. View at Publisher · View at Google Scholar
  • G. Liu, D. Shen, L. Jiao, and Y. Sun, “Nin one binding protein expression as a prognostic marker in prostate carcinoma,” Clinical and Translational Oncology, 2014. View at Publisher · View at Google Scholar
  • Masaki Shiota, Ario Takeuchi, Kenjiro Imada, Eiji Kashiwagi, YooHyun Song, Junichi Inokuchi, Katsunori Tatsugami, Takeshi Uchiumi, and Seiji Naito, “Inhibition of Protein Kinase C/Twist1 Signaling Augments Anticancer Effects of Androgen Deprivation and Enzalutamide in Prostate Cancer,” Clinical Cancer Research, vol. 20, no. 4, pp. 951–961, 2014. View at Publisher · View at Google Scholar
  • A.C. Tree, V.S. Khoo, N.J. van As, and M. Partridge, “Is Biochemical Relapse-free Survival After Profoundly Hypofractionated Radiotherapy Consistent with Current Radiobiological Models?,” Clinical Oncology, 2014. View at Publisher · View at Google Scholar
  • C Grenade, M A Phelps, and M A Villalona-Calero, “Race and Ethnicity in Cancer Therapy: What Have We Learned?,” Clinical Pharmacology & Therapeutics, 2014. View at Publisher · View at Google Scholar
  • Philip C. Calder, and Richard J. Deckelbaum, “Dietary fatty acids in health and disease,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 17, no. 2, pp. 111–115, 2014. View at Publisher · View at Google Scholar
  • Ulka Vaishampayan, “Therapeutic options and multifaceted treatment paradigms in metastatic castrate-resistant prostate cancer,” Current Opinion in Oncology, vol. 26, no. 3, pp. 265–273, 2014. View at Publisher · View at Google Scholar
  • Michael J. Solomon, Ker-Kan Tan, Richard Gideon Bromilow, and James C. H. Wong, “Bilateral Puborectalis Interposition Repair of Rectourethral Fistula,” Diseases of the Colon & Rectum, vol. 57, no. 1, pp. 133–139, 2014. View at Publisher · View at Google Scholar
  • Matt Shirley, and Paul L. McCormack, “Radium-223 Dichloride: A Review of Its Use in Patients with Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases,” Drugs, 2014. View at Publisher · View at Google Scholar
  • Sankar N Krishna, and Raymond C Bergan, “Therapeutic modulation of prostate cancer metastasis,” Future Medicinal Chemistry, vol. 6, no. 2, pp. 223–239, 2014. View at Publisher · View at Google Scholar
  • Julio Fernandez-Banet, Nikki P. Lee, Kin Tak Chan, Huan Gao, Xiao Liu, Wing Kin Sung, Winnie Tan, Sheung Tat Fan, Ronnie T. Poon, Shiyong Li, Keith Ching, Paul Rejto, Mao Mao, and Zhengyan Kan, “Decoding Complex Patterns of Genomic Rearrangement in Hepatocellular Carcinoma,” Genomics, 2014. View at Publisher · View at Google Scholar
  • Madhuwanti Srinivasan, Souresh Banerjee, Allison Palmer, Guoxing Zheng, Aoshuang Chen, Maarten C. Bosland, André Kajdacsy-Balla, Ramaswamy Kalyanasundaram, and Gnanasekar Munirathinam, “HMGB1 in Hormone-Related Cancer: a Potential Therapeutic Target,” Hormones and Cancer, 2014. View at Publisher · View at Google Scholar
  • Kathleen C. Torkko, R. Storey Wilson, M. Scott Lucia, and David G. Bostwick, “Prostatic atrophy: its spatial proximity to carcinoma and intraepithelial n eoplasia based on annotation of digital slides,” Human Pathology, vol. 45, no. 1, pp. 54–58, 2014. View at Publisher · View at Google Scholar
  • Bregje van Oorschot, Suzanne E. Hovingh, Perry D. Moerland, Jan Paul Medema, Lukas J.A. Stalpers, Harry Vrieling, and Nicolaas A.P. Franken, “Reduced Activity of Double-Strand Break Repair Genes in Prostate Cancer Patients With Late Normal Tissue Radiation Toxicity,” International Journal of Radiation Oncology*Biology*Physics, 2014. View at Publisher · View at Google Scholar
  • Dietmar Georg, Johannes Hopfgartner, Joanna Gòra, Peter Kuess, Gabriele Kragl, Daniel Berger, Neamat Hegazy, Gregor Goldner, and Petra Georg, “Dosimetric Considerations to Determine the Optimal Technique for Localized Prostate Cancer Among External Photon, Proton, or Carbon-Ion Therapy and High-Dose-Rate or Low-Dose-Rate Brachytherapy,” International Journal of Radiation Oncology*Biology*Physics, vol. 88, no. 3, pp. 715–722, 2014. View at Publisher · View at Google Scholar
  • Hyeyeol Bae, Yoh Matsuoka, Hiroshi Nakajima, Eisaku Ito, Hiroshi Tanaka, Miyako Oya, Takayuki Nakayama, Hideki Takeshita, Toshiki Kijima, Junichiro Ishioka, Noboru Numao, Fumitaka Koga, Kazutaka Saito, Takumi Akashi, Yasuhisa Fujii, and Kazunori Kihara, “Apparent diffusion coefficient value as a biomarker reflecting morphologica l and biological features of prostate cancer,” International Urology and Nephrology, vol. 46, no. 3, pp. 555–561, 2014. View at Publisher · View at Google Scholar
  • Jing Li, Chunquan Li, Junwei Han, Chunlong Zhang, Desi Shang, Qianlan Yao, Yunpeng Zhang, Yanjun Xu, Wei Liu, Meng Zhou, Haixiu Yang, Fei Su, and Xia Li, “The detection of risk pathways, regulated by miRNAs, via the integration of sample-matched miRNA-mRNA profiles and pathway structure,” Journal of Biomedical Informatics, 2014. View at Publisher · View at Google Scholar
  • Timothe Kambou, Barnabe Zango, and Ali Ouedraogo, “Knowledge and Awareness of Prostate Cancer Among the General Public in Burk ina Faso,” Journal of Cancer Education, vol. 29, no. 1, pp. 69–73, 2014. View at Publisher · View at Google Scholar
  • Nicholas H. Farina, Marie E. Wood, Scott D. Perrapato, Christopher S. Francklyn, Gary S. Stein, Janet L. Stein, and Jane B. Lian, “Standardizing Analysis of Circulating MicroRNA: Clinical and Biological Relevance,” Journal of Cellular Biochemistry, vol. 115, no. 5, pp. 805–811, 2014. View at Publisher · View at Google Scholar
  • G. Paolo Dotto, “Multifocal epithelial tumors and field cancerization: stroma as a primary determinant,” Journal of Clinical Investigation, vol. 124, no. 4, pp. 1446–1453, 2014. View at Publisher · View at Google Scholar
  • Nathan S. Consedine, Natalie L. Tuck, Camille R. Ragin, and Benjamin A. Spencer, “Beyond the Black Box: A Systematic Review of Breast, Prostate, Colorectal, and Cervical Screening Among Native and Immigrant African-Descent Caribbean Populations,” Journal of Immigrant and Minority Health, 2014. View at Publisher · View at Google Scholar
  • Y. Mao, I. Poschke, and R. Kiessling, “Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells,” Journal of Internal Medicine, 2014. View at Publisher · View at Google Scholar
  • Zhaoyong Feng, Patricia Landis, Bruce J. Trock, Jonathan I. Epstein, and H. Ballentine Carter, “Prostate Specific Antigen Velocity Risk Count Predicts Biopsy Reclassificat ion for Men with Very Low Risk Prostate Cancer,” Journal of Urology, vol. 191, no. 3, pp. 629–637, 2014. View at Publisher · View at Google Scholar
  • Sofia Nahavandi, Sara Baratchi, Rebecca Soffe, Shi-Yang Tang, Saeid Nahavandi, Arnan Mitchell, and Khashayar Khoshmanesh, “Microfluidic platforms for biomarker analysis,” Lab on a Chip, vol. 14, no. 9, pp. 1496, 2014. View at Publisher · View at Google Scholar
  • Isaac Adewole, Damali N. Martin, Makeda J. Williams, Clement Adebamowo, Kishor Bhatia, Christine Berling, Corey Casper, Karima Elshamy, Ahmed Elzawawy, Rita T. Lawlor, Rosa Legood, Sam M. Mbulaiteye, Folakemi T. Odedina, Olufunmilayo I. Olopade, Christopher O. Olopade, Donald M. Parkin, Timothy R. Rebbeck, Hana Ross, Luiz A. Santini, Julie Torode, Edward L. Trimble, Christopher P. Wild, Annie M. Young, and David J. Kerr, “Building capacity for sustainable research programmes for cancer in Africa,” Nature Reviews Clinical Oncology, 2014. View at Publisher · View at Google Scholar
  • Natalia Liem, Aadhitthya Vijayaraghavan, Gengbo Chen, Pei Li Lim, Kae-Jack Tay, Michelle Chang, John Soon Wah Low, Adita Joshi, Hong Hong Huang, Emarene Kalaw, Puay Hoon Tan, Wen-Son Hsieh, Wei Peng Yong, Joshi Alumkal, and Hong Gee Sim, “Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature i n Prostate Cancer,” Plos One, vol. 9, no. 3, 2014. View at Publisher · View at Google Scholar
  • Zeta Tak For Yu, Koh Meng Aw Yong, and Jianping Fu, “Microfluidic Blood Cell Sorting: Now and Beyond,” Small, 2014. View at Publisher · View at Google Scholar
  • Berat Cem Özgür, Ersin Köseoğlu, Ali İhsan Arık, Haşmet Sarıcı, Övünç Bilgin, Cem Nedim Yücetürk, Elif Özer, Eşref Oğuz Güven, Onur Telli, Ali Atan, and Muzaffer Eroğlu, “Synchronous bladder and prostate cancers in the specimens of radical cystoprostatectomy: A multicenter retrospective analysis,” The Kaohsiung Journal of Medical Sciences, 2014. View at Publisher · View at Google Scholar
  • Elizabeth A. Tindall, L. Richard Monare, Desiree C. Petersen, Smit van Zyl, Rae-Anne Hardie, Alpheus M. Segone, Philip A. Venter, M.S. Riana Bornman, and Vanessa M. Hayes, “Clinical presentation of prostate cancer in Black South Africans,” The Prostate, 2014. View at Publisher · View at Google Scholar
  • Petra Hudler, Nina Kocevar, and Radovan Komel, “Proteomic Approaches in Biomarker Discovery: New Perspectives in Cancer Diagnostics,” The Scientific World Journal, vol. 2014, pp. 1–18, 2014. View at Publisher · View at Google Scholar
  • James M. Jamison, Deborah Neal, and Jack L. Summers, “Synergistic Antitumor Cytotoxic Actions of Ascorbate and Menadione on Human Prostate (DU145) Cancer Cells In Vitro: Nucleus and Other Injuries Precedi ng Cell Death by Autoschizis,” Ultrastructural Pathology, vol. 38, no. 2, pp. 116–140, 2014. View at Publisher · View at Google Scholar
  • Monique J. Roobol, “International Perspectives on Screening,” Urologic Clinics of North America, vol. 41, no. 2, pp. 237–247, 2014. View at Publisher · View at Google Scholar
  • Dae-Seon Yoo, Seung Hyo Woo, Seok Cho, Seok Ho Kang, Sang Jin Kim, Sung Yul Park, Sang Hyub Lee, Seung Hyun Jeon, and Jinsung Park, “Practice Patterns of Urologists in Managing Korean Men Aged 40 Years or Younger With High Serum Prostate-specific Antigen Levels,” Urology, 2014. View at Publisher · View at Google Scholar
  • Adam D. Toll, “Urinary Cytomorphology and Clinical Correlates of Prostatic Small Cell Neur oendocrine Carcinoma,” Acta Cytologica, vol. 57, no. 5, pp. 495–500, 2013. View at Publisher · View at Google Scholar
  • Anna Pettersson, Ingela Turesson, Christina Persson, and Birgitta Johansson, “Assessing patients’ perceived bother from the gastrointestinal side effects of radiotherapy for localized prostate cancer: Initial questionnaire development and validation,” Acta Oncologica, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  • Kevin Krughoff, Khadijah Eid, Jason Phillips, Diliana Stoimenova, Daniel Smith, Colin O’Donnell, E. David Crawford, and Al Barqawi, “The Accuracy of Prostate Cancer Localization Diagnosed on Transrectal Ultrasound-Guided Biopsy Compared to 3-Dimensional Transperineal Approach,” Advances in Urology, vol. 2013, pp. 1–5, 2013. View at Publisher · View at Google Scholar
  • H. S. Park, J. D. Schoenfeld, R. B. Mailhot, M. Shive, R. I. Hartman, R. Ogembo, and L. A. Mucci, “Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis,” Annals of Oncology, 2013. View at Publisher · View at Google Scholar
  • Tanya I. Stoyanova, and Andrew S. Goldstein, “Identification, characterization and targeting of Docetaxel-resistant prost ate cancer cells,” Asian Journal of Andrology, vol. 15, no. 1, pp. 83–84, 2013. View at Publisher · View at Google Scholar
  • Yun-Fei Li, Shao-Feng Zhang, Tao-Tao Zhang, Lei Li, Wei Gan, Hong-Tao Jia, Sheng Xie, Hui-Hua Ji, and Da-Lin He, “Intermittent tri-weekly docetaxel plus bicalutamide in patients with castration-resistant prostate cancer: a single-arm prospective study using a historical control for comparison,” Asian Journal of Andrology, 2013. View at Publisher · View at Google Scholar
  • Dong Il Kang, Hong Koo Ha, Kweonsik Min, Jangho Yoon, Wansuk Kim, Won Ik Seo, Pil moon Kang, Soo Jin Jung, and Isaac Yi Kim, “Korean Prostate Cancer Patients Have Worse Disease Characteristics than the ir American Counterparts,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 11, pp. 6913–6917, 2013. View at Publisher · View at Google Scholar
  • Mathis Grossmann, Ada S. Cheung, and Jeffrey D. Zajac, “Androgens and prostate cancer; pathogenesis and deprivation therapy,” Best Practice & Research Clinical Endocrinology & Metabolism, 2013. View at Publisher · View at Google Scholar
  • Jean-Joseph Hoang, Silvère Baron, David H. Volle, Jean-Marc A. Lobaccaro, and Amalia Trousson, “Lipids, LXRs and prostate cancer: Are HDACs a new link?,” Biochemical Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Hai-Dong Yao, Qiong Wu, Zi-Wei Zhang, Shu Li, Xiao-Long Wang, Xin-Gen Lei, and Shi-Wen Xu, “Selenoprotein W serves as an antioxidant in chicken myoblasts,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1830, no. 4, pp. 3112–3120, 2013. View at Publisher · View at Google Scholar
  • Sophie E McGrath, Agnieszka Michael, Richard Morgan, and Hardev Pandha, “EN2: a novel prostate cancer biomarker,” Biomarkers in Medicine, vol. 7, no. 6, pp. 893–901, 2013. View at Publisher · View at Google Scholar
  • Awatef Ben Jemaa, Yosra Bouraoui, Sataa Sallami, Yassine Nouira, and Ridha Oueslati, “A Comparison of the Biological Features of Prostate Cancer with (PSA+, PSMA+) Profile according to RKIP,” BioMed Research International, vol. 2013, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • M. L. Verschoor, R. Ungard, A. Harbottle, J. P. Jakupciak, R. L. Parr, and G. Singh, “Mitochondria and Cancer: Past, Present, and Future,” Biomed Research International, 2013. View at Publisher · View at Google Scholar
  • Martin Andreas Røder, Klaus Brasso, Ib Jarle Christensen, Jørgen Johansen, Niels Christian Langkilde, Helle Hvarness, Steen Carlsson, Henrik Jakobsen, Michael Borre, and Peter Iversen, “Survival after radical prostatectomy for clinically localised prostate cancer: a population-based study,” BJU International, 2013. View at Publisher · View at Google Scholar
  • Bao-Li Chang, Lucinda Hughes, David Y.T. Chen, Laura Gross, Karen Ruth, and Veda N. Giri, “Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer,” BJU International, 2013. View at Publisher · View at Google Scholar
  • H. Ballentine Carter, “American Urological Association (AUA) Guideline on prostate cancer detection: process and rationale,” BJU International, vol. 112, no. 5, pp. 543–547, 2013. View at Publisher · View at Google Scholar
  • Christian Barré, Matthieu Thoulouzan, Geneviève Aillet, and Jean-Michel Nguyen, “Assessing the extirpative quality of a radical prostatectomy technique: categorisation and mapping of technical errors,” BJU International, 2013. View at Publisher · View at Google Scholar
  • Philip A. Fontenot, and Ahmed M. Mansour, “Reporting positive surgical margins after radical prostatectomy: time for standardization,” BJU International, 2013. View at Publisher · View at Google Scholar
  • Elizabeth A. Tindall, M. S. Riana Bornman, Smit van Zyl, Alpheus M. Segone, L. Richard Monare, and Philip A. Venter, “Addressing the contribution of previously described genetic and epidemiolog ical risk factors associated with increased prostate cancer risk and aggres sive disease within men from South Africa,” Bmc Urology, vol. 13, 2013. View at Publisher · View at Google Scholar
  • Joshua B. Stevens, Steven D. Horne, Batoul Y. Abdallah, Christine J. Ye, and Henry H. Heng, “Chromosomal instability and transcriptome dynamics in cancer,” Cancer and Metastasis Reviews, 2013. View at Publisher · View at Google Scholar
  • Archana Mukhopadhyay, Kayann Tabanor, Rathnam Chaguturu, and Jane V Aldrich, “Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment,” Cancer Biology & Therapy, vol. 14, no. 10, 2013. View at Publisher · View at Google Scholar
  • Dana E. Rathkopf, Joel Picus, Arif Hussain, Susan Ellard, Kim Nguyen Chi, Thomas Nydam, Erin Allen-Freda, Kaushal Kishor Mishra, Maria Grazia Porro, Howard I. Scher, and George Wilding, “A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer,” Cancer Chemotherapy and Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Isaac J. Powell, Greg Dyson, Susan Land, Julie Ruterbusch, Cathryn H. Bock, Steve Lenk, Mehsati Herawi, Richard Everson, Craig N. Giroux, Ann G. Schwartz, and Aliccia Bollig-Fischer, “Genes Associated with Prostate Cancer Are Differentially Expressed in Afric an American and European American Men,” Cancer Epidemiology Biomarkers & Prevention, vol. 22, no. 5, pp. 891–897, 2013. View at Publisher · View at Google Scholar
  • John P. A. Ioannidis, Brett M. Kaminski, Eric DeRycke, Scott Rogers, Muin J. Khoury, and Daniela Seminara, “Collaborative Cancer Epidemiology in the 21st Century: The Model of Cancer Consortia,” Cancer Epidemiology Biomarkers & Prevention, vol. 22, no. 12, pp. 2148–2160, 2013. View at Publisher · View at Google Scholar
  • Thippeswamy Gulappa, Ramadevi Subramani Reddy, Suman Suman, Alice M. Nyakeriga, and Chendil Damodaran, “Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells,” Cancer Letters, 2013. View at Publisher · View at Google Scholar
  • Brigitte N. Gomperts, Tonya C. Walser, Avrum Spira, and Steven M. Dubinett, “Enriching the Molecular Definition of the Airway "Field of Cancerization:" Establishing New Paradigms for the Patient at Risk for Lung Cancer,” Cancer Prevention Research, vol. 6, no. 1, pp. 4–7, 2013. View at Publisher · View at Google Scholar
  • Nicholas G. Zaorsky, Matthew T. Studenski, Adam P. Dicker, Leonard Gomella, and Robert B. Den, “Stereotactic body radiation therapy for prostate cancer: Is the technology ready to be the standard of care?,” Cancer Treatment Reviews, vol. 39, no. 3, pp. 212–218, 2013. View at Publisher · View at Google Scholar
  • S. Supiot, G. Créhange, I. Latorzeff, P. Pommier, A. Paumier, E. Rio, G. Delaroche, S. Guérif, C. Catton, J. Martin, and A. Lisbona, “Hypofractionnement à visée curative dans le cancer de la prostate,” Cancer/Radiothérapie, 2013. View at Publisher · View at Google Scholar
  • A. R. Verone, K. Duncan, A. Godoy, N. Yadav, A. Bakin, S. Koochekpour, J.-P. Jin, and H. V. Heemers, “Androgen-responsive Serum Response Factor target genes regulate prostate cancer cell migration,” Carcinogenesis, 2013. View at Publisher · View at Google Scholar
  • S Wang, J Huang, H Lyu, C-K Lee, J Tan, J Wang, and B Liu, “Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells,” Cell Death and Disease, vol. 4, no. 3, pp. e556, 2013. View at Publisher · View at Google Scholar
  • Zheng-Yuan Su, Tin Oo Khor, Limin Shu, Jong Hun Lee, Constance Lay-Lay Saw, Tien-Yuan Wu, Ying Huang, Nanjoo Suh, Chung S. Yang, Allan H. Conney, Qing Wu, and Ah-Ng Tony Kong, “ Epigenetic Reactivation of Nrf2 in Murine Prostate Cancer TRAMP C1 Cells by Natural Phytochemicals Z-Ligustilide and Radix Angelica Sinensis via Promoter CpG Demethylation ,” Chemical Research in Toxicology, vol. 26, no. 3, pp. 477–485, 2013. View at Publisher · View at Google Scholar
  • S. Dijkstra, P.F.A. Mulders, and J.A. Schalken, “Clinical Use of Novel Urine and Blood Based Prostate Cancer Biomarkers: a review,” Clinical Biochemistry, 2013. View at Publisher · View at Google Scholar
  • Sucharitha Balasubramaniam, Clay E. S. Comstock, Adam Ertel, Kwang Won Jeong, Michael R. Stallcup, Sankar Addya, Peter A. McCue, William F. Ostrander, Michael A. Augello, and Karen E. Knudsen, “Aberrant BAF57 Signaling Facilitates Prometastatic Phenotypes,” Clinical Cancer Research, vol. 19, no. 10, pp. 2657–2667, 2013. View at Publisher · View at Google Scholar
  • Patrick Berkovic, Gert De Meerleer, Louke Delrue, Bieke Lambert, Valérie Fonteyne, Nicolaas Lumen, Karel Decaestecker, Geert Villeirs, Philippe Vuye, and Piet Ost, “Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy,” Clinical Genitourinary Cancer, vol. 11, no. 1, pp. 27–32, 2013. View at Publisher · View at Google Scholar
  • Matthew C. Ward, Rahul D. Tendulkar, Jay P. Ciezki, and Eric A. Klein, “Future Directions From Past Experience: A Century of Prostate Radiotherapy,” Clinical Genitourinary Cancer, 2013. View at Publisher · View at Google Scholar
  • S. Sridharan, A. Dal Pra, C. Catton, R.G. Bristow, and P. Warde, “Locally Advanced Prostate Cancer: Current Controversies and Optimisation Opportunities,” Clinical Oncology, 2013. View at Publisher · View at Google Scholar
  • L. Dickinson, H.U. Ahmed, A. Kirkham, C. Allen, A. Freeman, J. Barber, R. Hindley, T. Leslie, C. Ogden, R. Persad, M.H. Winkler, and M. Emberton, “A Multi-Centre Prospective Development Study Evaluating Focal Therapy using High Intensity Focused Ultrasound for Localised Prostate Cancer: The INDEX Study,” Contemporary Clinical Trials, 2013. View at Publisher · View at Google Scholar
  • Jeffry L. Dean, “The Role of Tumor Suppressor Dysregulation in Prostate Cancer Progression,” Current Drug Targets, vol. 14, no. 4, pp. 460–471, 2013. View at Publisher · View at Google Scholar
  • F. El-Gehani, K. Joseph, A. Dechaphunkul, M. Kamal, D. Pertschy, P. Venner, S. Ghosh, and S. North, “Genitourinary small-cell carcinoma: a single-institution experience,” Current Oncology, vol. 20, no. 5, pp. 258–264, 2013. View at Publisher · View at Google Scholar
  • Sausan Abouharb, and Paul G. Corn, “Optimal Therapy Sequencing in Metastatic Castration-Resistant Prostate Cancer,” Current Oncology Reports, vol. 15, no. 3, pp. 217–223, 2013. View at Publisher · View at Google Scholar
  • Sonia Liberati, Maria Beatrice Morelli, Massimo Nabissi, and Matteo Santoni, “Oncogenic and Anti-Oncogenic Effects of Transient Receptor Potential Channe ls,” Current Topics In Medicinal Chemistry, vol. 13, no. 3, pp. 344–366, 2013. View at Publisher · View at Google Scholar
  • Phillip J. Gray, and Jason A. Efstathiou, “Proton Beam Radiation Therapy for Prostate Cancer—Is the Hype (and the Cost) Justified?,” Current Urology Reports, 2013. View at Publisher · View at Google Scholar
  • Gonzalo Rodríguez-Berriguete, Beatriz Sánchez-Espiridión, José R. Cansino, Gabriel Olmedilla, Pilar Martínez-Onsurbe, Manuel Sánchez-Chapado, Ricardo Paniagua, Benito Fraile, and Mar Royuela, “Clinical significance of both tumor and stromal expression of components of the IL-1 and TNF-α signaling pathways in prostate cancer,” Cytokine, 2013. View at Publisher · View at Google Scholar
  • J. Hübner, “Update 2013 Komplementäre Onkologie,” Der Onkologe, 2013. View at Publisher · View at Google Scholar
  • B.J. Schmitz-Dräger, G. Lümmen, E. Bismarck, and C. Fischer, “Metabolisches Syndrom und Prostatakarzinom,” Der Urologe, 2013. View at Publisher · View at Google Scholar
  • Yan-bing Ding, Bin Deng, You-sheng Huang, Wei-ming Xiao, Jian Wu, Yan-qing Zhang, Yuan-zhi Wang, Da-cheng Wu, Guo-tao Lu, and Ke-yan Wu, “A High Level of Integrin α6 Expression in Human Intrahepatic Cholangiocarcinoma Cells Is Associated with a Migratory and Invasive Phenotype,” Digestive Diseases and Sciences, vol. 58, no. 6, pp. 1627–1635, 2013. View at Publisher · View at Google Scholar
  • Elizabeth M. Hechenbleikner, Jill C. Buckley, and Elizabeth C. Wick, “Acquired Rectourethral Fistulas in Adults,” Diseases of the Colon & Rectum, vol. 56, no. 3, pp. 374–383, 2013. View at Publisher · View at Google Scholar
  • Sébastien Fortin, Kevin Brasseur, Nathalie Morin, Éric Asselin, and Gervais Bérubé, “New platinum(II) complexes conjugate at position 7α of 17β-acetyl-testosterone as new combi-molecules against prostate cancer: Design, synthesis, structure-activity relationships and biological evaluation,” European Journal of Medicinal Chemistry, 2013. View at Publisher · View at Google Scholar
  • Amit Bahl, “Metastatic castration-resistant prostate cancer. Part 1: the challenges of the disease and its treatment,” European Journal of Oncology Nursing, vol. 17, pp. S1–S6, 2013. View at Publisher · View at Google Scholar
  • Andrew Close, Clare Robertson, Stephen Rushton, Mark Shirley, Luke Vale, Craig Ramsay, and Robert Pickard, “Comparative Cost-effectiveness of Robot-assisted and Standard Laparoscopic Prostatectomy as Alternatives to Open Radical Prostatectomy for Treatment of Men with Localised Prostate Cancer: A Health Technology Assessment from the Perspective of the UK National Health Service,” European Urology, 2013. View at Publisher · View at Google Scholar
  • Axel Heidenreich, Patrick J. Bastian, Joaquim Bellmunt, Michel Bolla, Steven Joniau, Theodor van der Kwast, Malcolm Mason, Vsevolod Matveev, Thomas Wiegel, F. Zattoni, and Nicolas Mottet, “EAU Guidelines on Prostate Cancer, Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2014,” European Urology, 2013. View at Publisher · View at Google Scholar
  • Zhijun Wang, Jeffery Fan, Mandy Liu, Steven Yeung, Andy Chang, Moses SS Chow, Doreen Pon, and Ying Huang, “Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application,” Expert Opinion on Investigational Drugs, pp. 1–14, 2013. View at Publisher · View at Google Scholar
  • Rahul R Deshmukh, Sara M Schmitt, Clara Hwang, and Qing Ping Dou, “Chemotherapeutic inhibitors in the treatment of prostate cancer,” Expert Opinion on Pharmacotherapy, pp. 1–12, 2013. View at Publisher · View at Google Scholar
  • Guillaume Ploussard, and Pierre Mongiat-Artus, “Triptorelin in the management of prostate cancer,” Future Oncology, vol. 9, no. 1, pp. 93–102, 2013. View at Publisher · View at Google Scholar
  • Michael Blaise Cook, Zhaoming Wang, Edward D. Yeboah, Yao Tettey, Richard B. Biritwum, Andrew A. Adjei, Evelyn Tay, Ann Truelove, Shelley Niwa, Charles C. Chung, Annand P. Chokkalingam, Lisa W. Chu, Meredith Yeager, Amy Hutchinson, Kai Yu, Kristin A. Rand, Christopher A. Haiman, Robert N. Hoover, Ann W. Hsing, and Stephen J. Chanock, “A genome-wide association study of prostate cancer in West African men,” Human Genetics, 2013. View at Publisher · View at Google Scholar
  • Julie K. Bassett, Gianluca Severi, Allison M. Hodge, Robert J. MacInnis, Robert A. Gibson, John L. Hopper, Dallas R. English, and Graham G. Giles, “Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk,” International Journal of Cancer, 2013. View at Publisher · View at Google Scholar
  • Zaki Shaikhibrahim, Roopika Menon, Martin Braun, Anne Offermann, Angela Queisser, Diana Boehm, Wenzel Vogel, Kerstin Rüenauver, Christian Ruiz, Tobias Zellweger, Maria Svensson, Ove Andren, Glen Kristiansen, Nicolas Wernert, Lukas Bubendorf, Jutta Kirfel, Saskia Biskup, and Sven Perner, “ MED15 , encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer ,” International Journal of Cancer, 2013. View at Publisher · View at Google Scholar
  • Priya Bhosale, Aparna Balachandran, Raghu Vikram, Chitra Viswanathan, Homer Macapinlac, Eric Rohren, and Ramanujan Prativadi, “What Is the Clinical Significance of FDG Unexpected Uptake in the Prostate in Patients Undergoing PET/CT for Other Malignancies?,” International Journal of Molecular Imaging, vol. 2013, pp. 1–6, 2013. View at Publisher · View at Google Scholar
  • Sakthivel Muniyan, Nagendra Chaturvedi, Jennifer Dwyer, Chad LaGrange, William Chaney, and Ming-Fong Lin, “Human Prostatic Acid Phosphatase: Structure, Function and Regulation,” International Journal of Molecular Sciences, vol. 14, no. 5, pp. 10438–10464, 2013. View at Publisher · View at Google Scholar
  • Ines de Torres, Marina Rigau, Juan Morote, Mireia Olivan, Colin Cooper, Jaume Reventos, Jeremy Clark, Melania Montes, Eva Colas, Jacques Planas, Marta Garcia, Tamara Sequeiros, and Marta Llaurado, “The Present and Future of Prostate Cancer Urine Biomarkers,” International Journal Of Molecular Sciences, vol. 14, no. 6, pp. 12620–12649, 2013. View at Publisher · View at Google Scholar
  • James Farrell, Gyorgy Petrovics, and David G. McLeod, “Genetic and Molecular Differences in Prostate Carcinogenesis between Africa n American and Caucasian American Men,” International Journal of Molecular Sciences, vol. 14, no. 8, pp. 15510–15531, 2013. View at Publisher · View at Google Scholar